1-9 of 9
Jose Luis García
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immunoglobulin Heavy/Light Chain Ratio and Suppression of the Myeloma Non-Involved Heavy/Light Chain Pair Isotype Correlate with Poor Survival in Multiple Myeloma at Diagnosis and after Autologous Stem Cell Transplant

José Luís García de Veas Silva, Nuno Barbosa, Rafael Rios Tamayo, Carmen Bermudo Guitarte, Tiago M Pais, PhD, Teresa Rodríguez Ruiz
Journal: Blood
Blood (2016) 128 (22): 5647.
https://doi.org/10.1182/blood.V128.22.5647.5647
Published: 2016
Journal Articles

Sustained Overall Survival Benefit with Lenalidomide Plus Dexamethasone Versus No Treatment in Patients with Smoldering Myeloma at High Risk of Progression to Myeloma: Long Term Analysis

Maria-Victoria Mateos, MD PhD, Miguel-T Hernandez, Pilar Giraldo, MD PhD, Javier De La Rubia, Felipe De Arriba, Lucia Lopez-Corral, Laura Rosiñol, Bruno Paiva, PhD, Luis Palomera, MD PhD, Joan Bargay, MD, Albert Oriol, Felipe Prosper, MD, Javier Lopez, Sr., MD PhD, Jose-María Arguiñano, Nuria Quintana, Jose Luis Garcia, Joan Bladé, Juan José Lahuerta, MD PhD, Jesus San Miguel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3308.
https://doi.org/10.1182/blood.V128.22.3308.3308
Published: 2016
Journal Articles

A New Model for Risk Stratification in Patients with Newly Diagnosed Multiple Myeloma: Impact of Serum Free Light Chains in Prognosis

José Luís García de Veas Silva, Johanna Carolina Rojas Novoa, Carmen Bermudo Guitarte, Stephen Harding, PhD, Luisa Campos, Rafael Duro Millan
Journal: Blood
Blood (2015) 126 (23): 5338.
https://doi.org/10.1182/blood.V126.23.5338.5338
Published: 2015
Journal Articles

Multiple Myeloma with Prior Precursor Disease Shows Better Outcome

Rafael Ríos-Tamayo, MD, Juan Sáinz Pérez, Manuel Jurado, MD, Jose Manuel Puerta Puerta, MD, Pedro Antonio González Sierra, MD, Antonio Romero Aguilar, MD, Elisa Lopez Fernandez, MD, Lucia Moratalla Lopez, MD, José Luís García de Veas Silva, Teresa Rodríguez Ruiz, José Juan Jiménez Moleón, MD, María José Sánchez Pérez, MD
Journal: Blood
Blood (2015) 126 (23): 1756.
https://doi.org/10.1182/blood.V126.23.1756.1756
Published: 2015
Journal Articles

Long Term Follow-up on the Tretament of High Risk Smoldering Myeloma with Lenalidomide Plus Low Dose Dex (Rd) (phase III spanish trial): Persistent Benefit in Overall Survival

Maria-Victoria Mateos, MD PhD, Miguel T Hernandez, MD, Pilar Giraldo, MD PhD, Javier De La Rubia, Felipe de Arriba, Lucía López-Corral, MD PhD, Laura Rosiñol, MD PhD, Bruno Paiva, PhD, Luis Palomera, Joan Bargay, MD, Albert Oriol, MD, Felipe Prosper, MD, Javier López, Eduardo Olavarría, MD, Nuria Quintana, Jose Luis García, Joan Blade, Juan José Lahuerta, MD PhD, Jesus F. San Miguel
Journal: Blood
Blood (2014) 124 (21): 3465.
https://doi.org/10.1182/blood.V124.21.3465.3465
Published: 2014
Journal Articles

Value Of Serum Free Light Chains Ratio As New Biomarker Of High Prognostic Value In Patients With Newly Diagnosed Multiple Myeloma

José Luis García de Veas Silva, Carmen Bermudo, Stephen Harding, Rafael Duro Millán
Journal: Blood
Blood (2013) 122 (21): 1862.
https://doi.org/10.1182/blood.V122.21.1862.1862
Published: 2013
Journal Articles

Clinical and Biological Characterization of Patients with Low/Intermediate-1 Risk Myelodysplastic Syndrome and Iron Overload

David Ivars, PhD, Rosa Collado, PhD, Carmen Alguero, M Carmen Tormos, Laura Diaz, Jose Luis Garcia-Gimenez, PhD, Beatriz Arrizabalaga, MD, Mayte Orero, MD, PhD, Pedro Perez, MD, Magdalena Sanchez, MD, PhD, M Angeles Ruiz, MD, PhD, Nuria Yagüe, MD, Reyes Sancho-Tello, MD, Ana Regadera, MD, Mar Tormo, Mercedes Egea, Elena Vidal, J Enrique O'Connor, PhD, Guillermo T Saez, MD, PhD, Felix Carbonell, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4956.
https://doi.org/10.1182/blood.V120.21.4956.4956
Published: 2012
Journal Articles

Multicenter, Randomized, Open-Label, Phase III Trial of Lenalidomide-Dexamethasone (Len/dex) Vs Therapeutic Abstention in Smoldering Multiple Myeloma at High Risk of Progression to Symptomatic MM: Results of the First Interim Analysis.

Maria-Victoria Mateos, MD, PhD, Lucía López-Corral, Miguel T Hernández, Javier de la Rubia, Juan José Lahuerta, MD, PhD, Pilar Giraldo, MD, Joan Bargay, MD, Laura Rosiñol, Albert Oriol, MD, Jose García-Laraña, Luis Palomera, Felipe de Arriba, Felipe Prosper, MD, Mariluz Martino, MD, Ana-Isabel Teruel, José Hernández, Graça Esteves, Mario Mariz, Adrian Alegre, MD, J.L. Guzmán, Nuria Quintana, Jose-Luis Garcia, Jesús F. San-Miguel, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 614.
https://doi.org/10.1182/blood.V114.22.614.614
Published: 2009
Journal Articles

Characterization of Human Multiple Myeloma Cells with High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy

Albert Oriol, Ignasi Barba, Angels Barbera, Carles Arús, Jose-Luis Garcia-Dorado, Josep-Maria Ribera, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5122.
https://doi.org/10.1182/blood.V112.11.5122.5122
Published: 2008